Haleon Financial Statements From 2010 to 2024
| HLNCF Stock | USD 4.74 0.12 2.60% |
Check Haleon Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Haleon Plc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Haleon financial statements analysis is a perfect complement when working with Haleon Plc Valuation or Volatility modules.
Haleon |
Haleon plc Company Current Valuation Analysis
Haleon Plc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Haleon Plc Current Valuation | 46.45 B |
Most of Haleon Plc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Haleon plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Haleon plc has a Current Valuation of 46.45 B. This is 223.42% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 179.43% lower than that of the firm.
Haleon plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Haleon Plc's current stock value. Our valuation model uses many indicators to compare Haleon Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Haleon Plc competition to find correlations between indicators driving Haleon Plc's intrinsic value. More Info.Haleon plc is one of the top stocks in profit margin category among its peers. It is rated # 2 in operating margin category among its peers reporting about 1.53 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Haleon Plc's earnings, one of the primary drivers of an investment's value.About Haleon Plc Financial Statements
Haleon Plc stakeholders use historical fundamental indicators, such as Haleon Plc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Haleon Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Haleon Plc's assets and liabilities are reflected in the revenues and expenses on Haleon Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Haleon plc. Please read more on our technical analysis and fundamental analysis pages.
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 22000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Haleon Pink Sheet
When determining whether Haleon plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Haleon Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Haleon Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Haleon Plc Stock:Check out the analysis of Haleon Plc Correlation against competitors. For more detail on how to invest in Haleon Pink Sheet please use our How to Invest in Haleon Plc guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.